{"title":"Schnitzler Syndrome after COVID-19 Vaccination.","authors":"Mizuki Asako, Hitomi Matsunaga, Kazumasa Oka, Shuji Ueda","doi":"10.2169/internalmedicine.9598-22","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":77259,"journal":{"name":"Medicina interna (Bucharest, Romania : 1991)","volume":"46 3","pages":"2397"},"PeriodicalIF":0.0000,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424087/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicina interna (Bucharest, Romania : 1991)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2169/internalmedicine.9598-22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/5/31 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
COVID-19疫苗接种后的施尼茨勒综合征
一位86岁的日本妇女因白细胞增多症被诊断为Waldenström巨球蛋白血症。患者无症状,随访期间病情稳定。在她第一次接种COVID-19疫苗(辉瑞- biontech)的第二天,她的四肢出现了荨麻疹。虽然局部类固醇改善了皮疹,但在她接受第二次疫苗接种的第二天,皮疹恶化了;骨痛、全身乏力、白细胞增多(白细胞计数:11600 / μL)。皮肤活检显示血管周围和间质中性粒细胞浸润伴白细胞减少(图A、B),根据斯特拉斯堡标准诊断为明确的施尼茨勒综合征(1)。低剂量强的松龙(10mg /天)治疗后迅速反应,皮疹和全身症状消失。施尼茨勒综合征是一种自身炎症,以荨麻疹和免疫球蛋白M单克隆γ病为特征。淋巴细胞增生性疾病以免疫失调为特征,常导致自身免疫性疾病(2)。对于淋巴细胞增生性疾病患者,医生应注意COVID-19疫苗接种后的免疫并发症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。